Atlas Trials

To Explore the Protective Effect of SARS-CoV-2 Vaccination on Cancer Patients Infected With SARS-CoV-2

Clinical trial NCT05774171 · UNKNOWN

Trial details

NCT number
NCT05774171
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19 InfectionCOVID-19 Vaccine
Start date
2023-01-01
Primary completion
2023-12-31
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.